Skip to main content

Chronic Conditions and Patient-Centered Outcomes After Transcatheter Aortic Valve Intervention.

Publication ,  Journal Article
Wessler, BS; Stebbins, A; Alkhouli, M; Kumbhani, DJ; Kaneko, T; Thourani, V; Batchelor, W; Vesel, T; Marturano, C; Kimmelstiel, C; Resor, C ...
Published in: JACC Adv
November 2025

BACKGROUND: Transcatheter aortic valve intervention (TAVI) has revolutionized the care of older adults with aortic stenosis. OBJECTIVES: The objectives of the study were to examine associations between chronic conditions and outcomes after TAVI and to describe palliative care utilization rates. METHODS: This cohort study used the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy registry to identify patients who underwent TAVI and were eligible for linkage with Centers for Medicare & Medicaid Services claims data. The exposure was multiple chronic conditions (MCCs) in the year before TAVI. Associations between chronic conditions and outcomes were assessed using multivariable logistic regression. RESULTS: A total of 188,629 TAVI procedures were linked to Centers for Medicare & Medicaid Services claims. The median (IQR) age was 82.0 (76.0-87.0) years; 86,841 (46%) were female. Chronic conditions were associated with worse 1-year mortality (high MCC [≥6 conditions] vs low MCC [<4 chronic conditions], adjusted HR: 2.33 [95% CI: 2.22-2.44]). Chronic conditions were associated with lower Kansas City Cardiomyopathy Questionnaire at baseline (high MCC median score 37.5 [21.4-56.8] vs low MCC median score 55.7 [37.5-75.0], P < 0.001); however, the average improvement in Kansas City Cardiomyopathy Questionnaire after TAVI was large and appeared independent of chronic disease burden (median score change high MCC 28.7 [9.9-48.4] vs low MCC 24.5 [8.3-42.2], standardized difference +13.8%). Palliative care encounters were rare (8,946, 4.7%) and varied significantly across centers (range 0% to 25% of cases). CONCLUSIONS: Chronic conditions are associated with worse survival after TAVI. However, most patients with high MCC are alive 1 year after treatment, and quality of life improvements appear independent of chronic disease burden. These data help clarify expected health gains for patients with chronic conditions and symptomatic aortic stenosis.

Duke Scholars

Published In

JACC Adv

DOI

EISSN

2772-963X

Publication Date

November 2025

Volume

4

Issue

11 Pt 1

Start / End Page

102231

Location

United States
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wessler, B. S., Stebbins, A., Alkhouli, M., Kumbhani, D. J., Kaneko, T., Thourani, V., … Kent, D. M. (2025). Chronic Conditions and Patient-Centered Outcomes After Transcatheter Aortic Valve Intervention. JACC Adv, 4(11 Pt 1), 102231. https://doi.org/10.1016/j.jacadv.2025.102231
Wessler, Benjamin S., Amanda Stebbins, Mohamad Alkhouli, Dharam J. Kumbhani, Tsuyoshi Kaneko, Vinod Thourani, Wayne Batchelor, et al. “Chronic Conditions and Patient-Centered Outcomes After Transcatheter Aortic Valve Intervention.JACC Adv 4, no. 11 Pt 1 (November 2025): 102231. https://doi.org/10.1016/j.jacadv.2025.102231.
Wessler BS, Stebbins A, Alkhouli M, Kumbhani DJ, Kaneko T, Thourani V, et al. Chronic Conditions and Patient-Centered Outcomes After Transcatheter Aortic Valve Intervention. JACC Adv. 2025 Nov;4(11 Pt 1):102231.
Wessler, Benjamin S., et al. “Chronic Conditions and Patient-Centered Outcomes After Transcatheter Aortic Valve Intervention.JACC Adv, vol. 4, no. 11 Pt 1, Nov. 2025, p. 102231. Pubmed, doi:10.1016/j.jacadv.2025.102231.
Wessler BS, Stebbins A, Alkhouli M, Kumbhani DJ, Kaneko T, Thourani V, Batchelor W, Vesel T, Marturano C, Kimmelstiel C, Resor C, Weintraub A, Boyd C, Kosinski A, Vemulapalli S, Udelson JE, Kent DM. Chronic Conditions and Patient-Centered Outcomes After Transcatheter Aortic Valve Intervention. JACC Adv. 2025 Nov;4(11 Pt 1):102231.

Published In

JACC Adv

DOI

EISSN

2772-963X

Publication Date

November 2025

Volume

4

Issue

11 Pt 1

Start / End Page

102231

Location

United States